title: Oncolytic immunotherapy: an emerging new modality for the treatment of cancer.
authors.affiliation: Replimune Ltd, Oxford, UK rob@replimune.com.
authors.forename: R S
authors.initials: RS
authors.lastname: Coffin
mesh_terms: D000074322:Antineoplastic Agents, Immunological / Q000008:administration & dosage*; D002986:Clinical Trials as Topic / Q000379:methods; D004359:Drug Therapy, Combination; D006801:Humans; D007167:Immunotherapy / Q000379:methods / Q000639:trends*; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology*; D050130:Oncolytic Virotherapy / Q000379:methods / Q000639:trends*; D016896:Treatment Outcome
chemical_list: D000074322:Antineoplastic Agents, Immunological